- Number of people
- 31 (51.61% female)
- People with ≥2 records
- 41.94%
- Median duration from first to last measurement
- 0.62 years
Blasts/100 cells in Bone marrow
Coding
Definition
- OMOP Concept ID
- 3009992— open in OHDSI Athena.
- Part of collection
- Blasts/100 cells with 0 other OMOP concept — open in OHDSI Athena.
OMOP mapping QC
| OMOP concept ID | Test name | Measurement unit (harmonized unit) | N people | N records | Missing measurement value | Harmonized value distribution |
Test outcome
NA
N
A
AA
L
LL
H
HH
|
|---|---|---|---|---|---|---|---|
| 3009992 | bm-blastit | % (%) | 31 | 51 | 0.00% |
|
Cohort
- Number of people
- 31 (51.61% female)
Year of birth distribution
Age at first measurement
Age at last measurement
Age at start of registry
Duration from first to last measurement
Statistics
- People with ≥2 records
- 41.94%
- Median number of measurements per person
- 1.0
- Median duration from first to last measurement
- 0.62 years
Number of measurements over the years
Number of measurements per person
Distribution of lab values
Reference range
N people
N records
—
31
55
Value range per person
LabWAS
Endpoint
People with measurements
Mean N measurements
Mean measured value
Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
17
6
23.21
11.65
1.8
1.5
16.29
13.00
%
—
17
6
18
5
20.00
10.51
1.8
1.4
15.28
30.60
%
—
18
5
18
12
10.10
8.73
1.5
2.0
23.56
9.58
%
0.82
18
12
15
7
12.52
7.74
1.9
1.4
6.40
32.71
%
—
15
7
15
7
12.52
7.74
1.9
1.4
6.40
32.71
%
—
15
7
16
15
8.30
7.35
1.9
1.6
10.81
24.53
%
0.79
16
15
16
13
7.77
6.77
2.1
1.5
11.56
20.54
%
0.48
16
13
9
6
15.01
5.90
2.2
1.8
8.44
5.50
%
—
9
6
12
10
8.75
5.72
2.3
1.5
9.17
19.20
%
—
12
10
15
16
6.24
5.68
2.0
1.6
12.00
22.56
%
0.57
15
16
10
11
9.09
5.27
1.9
1.8
13.20
11.18
%
—
10
11
11
17
6.34
4.69
2.5
1.3
7.36
21.65
%
1.00
11
17
14
16
4.85
4.32
1.6
1.8
17.79
18.13
%
0.01
14
16
12
18
4.45
3.67
2.2
1.4
6.83
25.39
%
1.42
12
18
6
6
10.01
3.49
2.0
1.7
20.83
5.83
%
—
6
6
6
7
8.58
3.26
2.0
2.0
20.83
5.14
%
—
6
7
11
16
4.06
3.09
1.8
1.9
9.55
22.88
%
0.80
11
16
8
12
4.50
2.64
1.9
1.7
7.75
28.92
%
—
8
12
8
9
4.64
2.56
1.9
1.9
9.25
11.89
%
—
8
9
5
19
2.61
1.20
2.2
1.6
5.00
20.11
%
—
5
19
5
19
2.35
1.06
1.6
1.5
29.40
16.37
%
—
5
19
0
18
0.00
0.81
0.0
1.7
—
13.44
—
0
18
0
20
0.00
0.80
0.0
1.5
—
16.05
—
0
20
7
20
1.90
0.75
2.0
1.8
21.00
18.00
%
—
7
20
6
21
1.83
0.60
2.0
1.5
25.50
14.14
%
—
6
21
0
21
0.00
0.58
0.0
1.6
—
19.24
—
0
21
0
14
0.00
0.41
0.0
1.7
—
17.93
—
0
14
0
14
0.00
0.41
0.0
2.1
—
7.43
—
0
14
5
17
1.47
0.40
1.8
1.7
6.40
20.29
%
—
5
17
5
22
1.44
0.39
2.0
1.6
16.40
20.50
%
—
5
22
6
23
1.34
0.34
1.3
1.7
18.00
18.65
%
—
6
23
5
21
1.33
0.23
2.2
1.5
30.20
14.14
%
—
5
21
5
20
1.26
0.23
1.6
1.7
2.20
18.00
%
—
5
20
0
10
0.00
0.21
0.0
1.9
—
9.50
—
0
10
0
10
0.00
0.21
0.0
2.0
—
8.80
—
0
10
0
10
0.00
0.21
0.0
1.9
—
9.50
—
0
10
0
10
0.00
0.21
0.0
1.9
—
9.00
—
0
10
0
6
0.00
0.00
0.0
1.8
—
9.67
—
0
6
0
5
0.00
0.00
0.0
2.0
—
18.20
—
0
5
0
5
0.00
0.00
0.0
1.8
—
13.40
—
0
5
Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo
0
7
0.00
-0.00
0.0
1.9
—
12.57
—
0
7
0
6
0.00
-0.00
0.0
2.0
—
11.67
—
0
6
0
8
0.00
-0.00
0.0
1.9
—
20.38
—
0
8
0
5
0.00
-0.00
0.0
2.0
—
2.20
—
0
5
0
8
0.00
-0.00
0.0
2.0
—
9.00
—
0
8
0
6
0.00
-0.00
0.0
1.7
—
11.33
—
0
6
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0
6
0.00
-0.00
0.0
2.0
—
11.67
—
0
6
0
7
0.00
-0.00
0.0
1.7
—
15.71
—
0
7
0
8
0.00
-0.00
0.0
2.0
—
9.00
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
13.80
—
0
5
0
7
0.00
-0.00
0.0
2.0
—
5.14
—
0
7
0
8
0.00
-0.00
0.0
2.3
—
9.63
—
0
8
0
5
0.00
-0.00
0.0
1.8
—
6.80
—
0
5
0
7
0.00
-0.00
0.0
1.9
—
10.43
—
0
7